A Long-Term Follow-Up Study of Patients With MPS IIIA Treated With ABO-102

key information

study id #: NCT04360265

condition: Mucopolysaccharidosis III-A

status: Recruiting


This is a multicenter, non-interventional, long-term follow-up study in participants from prior interventional trials involving the administration of ABO-102. Eligible participants will have up to 5 scheduled visits with assessments as specified in the schedule of assessments.

intervention: ABO-102


last updated: February 26, 2022